Traws Pharma Inc. (TRAW)
TRAW trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.4101
-1.42% on the day
Market cap
$6.3M
Nano cap
Revenue · 2025
$2.8M
+1134.5% on 2024
Net income · 2025
$9.2M
328.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | TRAW on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2013 |
| SEC CIK | 0001130598 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.8M |
| Net income | $9.2M |
| Operating income | -$17.9M |
| Net margin | 328.7% |
| Operating margin | -640.7% |
| Revenue growth | +1134.5% |
| Cash | Not in SEC XBRL data |
| Total assets | $10.6M |
| P/E (computed) | 0.7× |
| P/S (computed) | 2.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-07-10 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report FORM 8-K | 8-K | 2026-08-14 |
| Latest proxy | PRE 14A | 2026-10-08 |
Source: SEC EDGAR submissions feed, 984 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ENVB | Enveric Biosciences Inc. | $1.40 | -4.76% | $6.3M |
| FBLG | FibroBiologics Inc. | $0.9599 | -4.01% | $6.5M |
| ALZN | Alzamend Neuro Inc. | $1.35 | +3.05% | $6.5M |
| BGMS | Bio Green Med Solution Inc. | $0.9199 | -7.08% | $6.1M |
| IMNN | Imunon Inc. | $1.07 | 0.00% | $6.0M |
| NRSN | NeuroSense Therapeutics Ltd. | $3.49 | +0.29% | $6.6M |
| ACXP | Acurx Pharmaceuticals Inc. | $1.20 | -6.25% | $6.7M |
| CANF | Can-Fite Biopharma Ltd | $1.95 | 0.00% | $5.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier